Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?
Julia S. Johansen(Hvidovre Hospital), Paul A. Price(University of California, San Diego), Benny Vittrup Jensen(Herlev Hospital), Anne Roslind(Herlev Hospital), Dorte Nielsen(University of Copenhagen)
Cited by 364
Related Papers
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.
|Journal of Clinical Investigation|1980|660
Effect of Obesity on Prognosis After Early-Stage Breast Cancer
|Journal of Clinical Oncology|2010|600
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
|Nature Communications|2015|484